IBDEI15D ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20243,1,5,0)
 ;;=5^444.22
 ;;^UTILITY(U,$J,358.3,20243,2)
 ;;=^269790
 ;;^UTILITY(U,$J,358.3,20244,0)
 ;;=451.11^^107^1255^72
 ;;^UTILITY(U,$J,358.3,20244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20244,1,4,0)
 ;;=4^Phleb/Thrombophl Fem V Deep
 ;;^UTILITY(U,$J,358.3,20244,1,5,0)
 ;;=5^451.11
 ;;^UTILITY(U,$J,358.3,20244,2)
 ;;=^269811
 ;;^UTILITY(U,$J,358.3,20245,0)
 ;;=451.19^^107^1255^45
 ;;^UTILITY(U,$J,358.3,20245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20245,1,4,0)
 ;;=4^Deep Phlebitis,Leg NEC
 ;;^UTILITY(U,$J,358.3,20245,1,5,0)
 ;;=5^451.19
 ;;^UTILITY(U,$J,358.3,20245,2)
 ;;=^269812
 ;;^UTILITY(U,$J,358.3,20246,0)
 ;;=451.81^^107^1255^52
 ;;^UTILITY(U,$J,358.3,20246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20246,1,4,0)
 ;;=4^Iliac Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,20246,1,5,0)
 ;;=5^451.81
 ;;^UTILITY(U,$J,358.3,20246,2)
 ;;=^269814
 ;;^UTILITY(U,$J,358.3,20247,0)
 ;;=454.0^^107^1255^55
 ;;^UTILITY(U,$J,358.3,20247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20247,1,4,0)
 ;;=4^Leg Varicosity w/ Ulcer
 ;;^UTILITY(U,$J,358.3,20247,1,5,0)
 ;;=5^454.0
 ;;^UTILITY(U,$J,358.3,20247,2)
 ;;=^125410
 ;;^UTILITY(U,$J,358.3,20248,0)
 ;;=454.1^^107^1255^54
 ;;^UTILITY(U,$J,358.3,20248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20248,1,4,0)
 ;;=4^Leg Varicosity w/ Inflam
 ;;^UTILITY(U,$J,358.3,20248,1,5,0)
 ;;=5^454.1
 ;;^UTILITY(U,$J,358.3,20248,2)
 ;;=^125435
 ;;^UTILITY(U,$J,358.3,20249,0)
 ;;=454.2^^107^1255^97
 ;;^UTILITY(U,$J,358.3,20249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20249,1,4,0)
 ;;=4^Varicose Leg Ulcer/Inflam
 ;;^UTILITY(U,$J,358.3,20249,1,5,0)
 ;;=5^454.2
 ;;^UTILITY(U,$J,358.3,20249,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,20250,0)
 ;;=454.9^^107^1255^18
 ;;^UTILITY(U,$J,358.3,20250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20250,1,4,0)
 ;;=4^Asymptomatic Varicose Veins
 ;;^UTILITY(U,$J,358.3,20250,1,5,0)
 ;;=5^454.9
 ;;^UTILITY(U,$J,358.3,20250,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,20251,0)
 ;;=459.81^^107^1255^100
 ;;^UTILITY(U,$J,358.3,20251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20251,1,4,0)
 ;;=4^Venous Insufficiency NOS
 ;;^UTILITY(U,$J,358.3,20251,1,5,0)
 ;;=5^459.81
 ;;^UTILITY(U,$J,358.3,20251,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,20252,0)
 ;;=457.1^^107^1255^59
 ;;^UTILITY(U,$J,358.3,20252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20252,1,4,0)
 ;;=4^Lymphedema,Other
 ;;^UTILITY(U,$J,358.3,20252,1,5,0)
 ;;=5^457.1
 ;;^UTILITY(U,$J,358.3,20252,2)
 ;;=^87693
 ;;^UTILITY(U,$J,358.3,20253,0)
 ;;=593.81^^107^1255^76
 ;;^UTILITY(U,$J,358.3,20253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20253,1,4,0)
 ;;=4^Renal Vascular Disorder
 ;;^UTILITY(U,$J,358.3,20253,1,5,0)
 ;;=5^593.81
 ;;^UTILITY(U,$J,358.3,20253,2)
 ;;=^270382
 ;;^UTILITY(U,$J,358.3,20254,0)
 ;;=557.0^^107^1255^9
 ;;^UTILITY(U,$J,358.3,20254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20254,1,4,0)
 ;;=4^AC Vasc Insuff Intestine
 ;;^UTILITY(U,$J,358.3,20254,1,5,0)
 ;;=5^557.0
 ;;^UTILITY(U,$J,358.3,20254,2)
 ;;=^2700
 ;;^UTILITY(U,$J,358.3,20255,0)
 ;;=557.1^^107^1255^98
 ;;^UTILITY(U,$J,358.3,20255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20255,1,4,0)
 ;;=4^Vasc Insuff Intest Chr
 ;;^UTILITY(U,$J,358.3,20255,1,5,0)
 ;;=5^557.1
 ;;^UTILITY(U,$J,358.3,20255,2)
 ;;=^270251
 ;;^UTILITY(U,$J,358.3,20256,0)
 ;;=557.9^^107^1255^99
 ;;^UTILITY(U,$J,358.3,20256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20256,1,4,0)
 ;;=4^Vasc Insuff Intest NOS
 ;;^UTILITY(U,$J,358.3,20256,1,5,0)
 ;;=5^557.9
 ;;^UTILITY(U,$J,358.3,20256,2)
 ;;=^270252
 ;;^UTILITY(U,$J,358.3,20257,0)
 ;;=585.9^^107^1255^53
 ;;
 ;;$END ROU IBDEI15D
